Amarin Corp Plc (AMRN)

[sstyles]

Great recap. What everyone seems to gloss over is that it’s the threat of loss that just became more real for Hikma. Put aside whether Amarin will prevail at trial, the question is can Hikma survive such loss. Hikma is not Teva. Teva can afford to pay significant damages...Hikma cannot. Look at their market cap. This has become very asymetric with significant downside for Hikma.

Amarin just has to survive summary judgment and get to trial....I think today’s hearing makes that path to trial a lot easier. Our case will be in front of a jury this time. If Hikma rolls the dice and decides to see this thing thru trial and they lose...the damages could be very difficult for them to bare.

The threat of loss has me most excited. Yesterday’s hearing was very favorable for Amarin.

Hatch Waxman never said it was legal to infringe on a patent. Of course we all know that was being done but fortunately for Amarin this case brought it to light.

I am extremely pleased with how the hearing went.